Remove Biotech Remove Capital Remove Commerce Remove Due Diligence
article thumbnail

M&A Trends and Outlook for 2023

Alpha Sense BI

Around the world, investors are favoring companies that have proven their profitability and that can demonstrate how they have successfully utilized their capital. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97
article thumbnail

Technology Industry Trends and Outlook in 2024

Alpha Sense BI

On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. Over the past few years, the technology industry has experienced dramatic highs and lows. 2020 and 2021 were marked by increased innovation, accelerated growth, and workforce expansion.

article thumbnail

Engage3 Team

Engage3

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. Safaii Board Member Matthew is the founder of Arrowroot Capital. He holds B.A.

Retail 52